172 related articles for article (PubMed ID: 33664437)
1. Prolonged cetuximab treatment promotes p27
Okuyama K; Suzuki K; Naruse T; Tsuchihashi H; Yanamoto S; Kaida A; Miura M; Umeda M; Yamashita S
Sci Rep; 2021 Mar; 11(1):5259. PubMed ID: 33664437
[TBL] [Abstract][Full Text] [Related]
2. Nicotine promotes lymph node metastasis and cetuximab resistance in head and neck squamous cell carcinoma.
Shimizu R; Ibaragi S; Eguchi T; Kuwajima D; Kodama S; Nishioka T; Okui T; Obata K; Takabatake K; Kawai H; Ono K; Okamoto K; Nagatsuka H; Sasaki A
Int J Oncol; 2019 Jan; 54(1):283-294. PubMed ID: 30431077
[TBL] [Abstract][Full Text] [Related]
3. SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.
Barzegar M; Ma S; Zhang C; Chen X; Gu Y; Shang C; Jiang X; Yang J; Nathan CA; Yang S; Huang S
Br J Cancer; 2017 Oct; 117(8):1154-1163. PubMed ID: 28873083
[TBL] [Abstract][Full Text] [Related]
4. ABT-751 Induces Multiple Anticancer Effects in Urinary Bladder Urothelial Carcinoma-Derived Cells: Highlighting the Induction of Cytostasis through the Inhibition of
Dehghanian SZ; Pan CT; Lee JM; Shiue YL
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478005
[TBL] [Abstract][Full Text] [Related]
5. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
6. Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.
Li Z; Liao J; Yang Z; Choi EY; Lapidus RG; Liu X; Cullen KJ; Dan H
Br J Cancer; 2019 Feb; 120(3):306-316. PubMed ID: 30585254
[TBL] [Abstract][Full Text] [Related]
7. Predictive Value of EGFR-PI3K-AKT-mTOR-Pathway Inhibitor Biomarkers for Head and Neck Squamous Cell Carcinoma: A Systematic Review.
de Kort WWB; Spelier S; Devriese LA; van Es RJJ; Willems SM
Mol Diagn Ther; 2021 Mar; 25(2):123-136. PubMed ID: 33686517
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells.
Li F; Dong X; Lin P; Jiang J
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29360760
[TBL] [Abstract][Full Text] [Related]
9. The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models.
D'Amato V; Rosa R; D'Amato C; Formisano L; Marciano R; Nappi L; Raimondo L; Di Mauro C; Servetto A; Fusciello C; Veneziani BM; De Placido S; Bianco R
Br J Cancer; 2014 Jun; 110(12):2887-95. PubMed ID: 24823695
[TBL] [Abstract][Full Text] [Related]
10. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
11. Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximab.
Ather F; Hamidi H; Fejzo MS; Letrent S; Finn RS; Kabbinavar F; Head C; Wong SG
PLoS One; 2013; 8(2):e56112. PubMed ID: 23405260
[TBL] [Abstract][Full Text] [Related]
12. Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines.
Ling YH; Li T; Yuan Z; Haigentz M; Weber TK; Perez-Soler R
Mol Pharmacol; 2007 Aug; 72(2):248-58. PubMed ID: 17456787
[TBL] [Abstract][Full Text] [Related]
13. Anti-epidermal growth factor receptor monoclonal antibody 225 upregulates p27(KIP1) and p15(INK4B) and induces G1 arrest in oral squamous carcinoma cell lines.
Kiyota A; Shintani S; Mihara M; Nakahara Y; Ueyama Y; Matsumura T; Tachikawa T; Wong DT
Oncology; 2002; 63(1):92-8. PubMed ID: 12187077
[TBL] [Abstract][Full Text] [Related]
14. Adenosine Attenuates Human Coronary Artery Smooth Muscle Cell Proliferation by Inhibiting Multiple Signaling Pathways That Converge on Cyclin D.
Dubey RK; Fingerle J; Gillespie DG; Mi Z; Rosselli M; Imthurn B; Jackson EK
Hypertension; 2015 Dec; 66(6):1207-19. PubMed ID: 26416848
[TBL] [Abstract][Full Text] [Related]
15. Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin.
Sun SH; Huang HC; Huang C; Lin JK
Eur J Pharmacol; 2012 Sep; 690(1-3):22-30. PubMed ID: 22705896
[TBL] [Abstract][Full Text] [Related]
16. Neuregulin Signaling Is a Mechanism of Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma.
Baro M; Lopez Sambrooks C; Burtness BA; Lemmon MA; Contessa JN
Mol Cancer Ther; 2019 Nov; 18(11):2124-2134. PubMed ID: 31387891
[TBL] [Abstract][Full Text] [Related]
17. Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity.
Busse D; Doughty RS; Ramsey TT; Russell WE; Price JO; Flanagan WM; Shawver LK; Arteaga CL
J Biol Chem; 2000 Mar; 275(10):6987-95. PubMed ID: 10702262
[TBL] [Abstract][Full Text] [Related]
18. Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer.
Nair S; Trummell HQ; Rajbhandari R; Thudi NK; Nozell SE; Warram JM; Willey CD; Yang ES; Placzek WJ; Bonner JA; Bredel M
PLoS One; 2020; 15(2):e0229077. PubMed ID: 32069320
[TBL] [Abstract][Full Text] [Related]
19. Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathway.
Wu TK; Ou YC; Chen YP; Huang FM; Pan YR; Lee CJ
Anticancer Res; 2021 Aug; 41(8):3789-3799. PubMed ID: 34281838
[TBL] [Abstract][Full Text] [Related]
20. TRIP6 regulates p27 KIP1 to promote tumorigenesis.
Lin VT; Lin VY; Lai YJ; Chen CS; Liu K; Lin WC; Lin FT
Mol Cell Biol; 2013 Apr; 33(7):1394-409. PubMed ID: 23339869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
